StockData
Glucotrack, Inc. logo

Glucotrack, Inc. (GCTK) stock

GCTKOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.68−0.04 (-5.56%)

Close on Oct 19, 2026Market cap $3.43MP/E 0.0Yield –

Glucotrack total assets

Total assets on the balance sheet at the end of each period.

Glucotrack's total assets was $1.50M at Jun 30, 2026. For fiscal 2025 it was $7.84M, up 32.1% from the year before. Over ten years it grew 13.9% a year on average. The highest annual figure on record is $10.61M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.84M+32.1%
FY2024Dec 31, 2024$5.93M+20.9%
FY2023Dec 31, 2023$4.91M+101.2%
FY2022Dec 31, 2022$2.44M-61.1%
FY2021Dec 31, 2021$6.27M-40.9%
FY2020Dec 31, 2020$10.61M+867.7%
FY2019Dec 31, 2019$1.10M+59.3%
FY2018Dec 31, 2018$688.19K-58.8%
FY2017Dec 31, 2017$1.67M-32.2%
FY2016Dec 31, 2016$2.46M+15.4%
FY2015Dec 31, 2015$2.13M-66.4%
FY2014Dec 31, 2014$6.35M+130.3%
FY2013Dec 31, 2013$2.76M+238.4%
FY2012Dec 31, 2012$814.57K-62.7%
FY2011Dec 31, 2011$2.18M+23.3%
FY2010Dec 31, 2010$1.77M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.50M-85.4%
Q1 FY2026Mar 31, 2026$4.36M-54.7%
Q4 FY2025Dec 31, 2025$7.84M+32.1%
Q3 FY2025Sep 30, 2025$8.29M+903.6%
Q2 FY2025Jun 30, 2025$10.21M+1579.3%
Q1 FY2025Mar 31, 2025$9.61M+356.4%
Q4 FY2024Dec 31, 2024$5.93M+20.9%
Q3 FY2024Sep 30, 2024$826.00K-88.5%
Q2 FY2024Jun 30, 2024$608.00K-93.2%
Q1 FY2024Mar 31, 2024$2.11M+68.3%
Q4 FY2023Dec 31, 2023$4.91M+101.2%
Q3 FY2023Sep 30, 2023$7.20M+104.9%
Q2 FY2023Jun 30, 2023$8.98M+108.1%
Q1 FY2023Mar 31, 2023$1.25M-76.7%
Q4 FY2022Dec 31, 2022$2.44M-61.1%
Q3 FY2022Sep 30, 2022$3.51M-54.0%
Q2 FY2022Jun 30, 2022$4.32M-49.8%
Q1 FY2022Mar 31, 2022$5.36M-44.3%
Q4 FY2021Dec 31, 2021$6.27M-40.9%
Q3 FY2021Sep 30, 2021$7.63M-33.5%
Q2 FY2021Jun 30, 2021$8.61M-29.5%
Q1 FY2021Mar 31, 2021$9.63M-27.8%
Q4 FY2020Dec 31, 2020$10.61M+867.7%
Q3 FY2020Sep 30, 2020$11.47M+481.3%
Q2 FY2020Jun 30, 2020$12.21M+299.8%
Q1 FY2020Mar 31, 2020$13.33M+1489.0%
Q4 FY2019Dec 31, 2019$1.10M+59.3%
Q3 FY2019Sep 30, 2019$1.97M-19.7%
Q2 FY2019Jun 30, 2019$3.06M+103.4%
Q1 FY2019Mar 31, 2019$839.10K-55.9%
Q4 FY2018Dec 31, 2018$688.19K-58.8%
Q3 FY2018Sep 30, 2018$2.46M-7.2%
Q2 FY2018Jun 30, 2018$1.50M-55.7%
Q1 FY2018Mar 31, 2018$1.90M-49.8%
Q4 FY2017Dec 31, 2017$1.67M-32.2%
Q3 FY2017Sep 30, 2017$2.65M+30.5%
Q2 FY2017Jun 30, 2017$3.39M–
Q1 FY2017Mar 31, 2017$3.80M–
Q4 FY2016Dec 31, 2016$2.46M–
Q3 FY2016Sep 30, 2016$2.03M–

More Glucotrack figures

See a number that looks wrong?